Podcast 27 Dec 2024
Cell therapy
- Latest Posts
In Depth 9 Dec 2024
CAR-T cell therapy for lupus: An emerging field with great potential
Discover how the emerging field of using CAR-T cell therapy to treat lupus could offer a potential cure for the autoimmune disorder.
Unlocking consistency in ATMP development: How cryopreservation strengthens Europe’s cell therapy supply chain
Discover how innovative cell therapy cryopreservation solutions are strengthening Europe’s ATMP supply chain.
In Depth 30 Oct 2024
Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies?
Discover how next-generation “switchable” CAR-T cells could improve both the safety and efficacy of CAR-T therapies.
News and Trends 21 Oct 2024
Turning back time with cellular reprogramming: Shift raises $16 million in seed funding
As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related diseases.
In Depth 7 Oct 2024
Spinal cord injury: Are we getting closer to a treatment?
Delve into the spinal cord injury treatment landscape with a few pharmaceutical approaches that could tackle this complex condition.
ADVERTISEMENT
ADVERTISEMENT
News and Trends 3 Oct 2024
Resolution Therapeutics raises $85 million to advance its macrophage therapy
Find out about Resolution Therapeutics’ macrophage therapy, as it just raised $85 million in a series B round.
Navigating your path to globalization: Untangling the regulatory maze of the Advanced Therapies supply chain
Discover how Cryoport Systems can help you navigate EMEA regulations and manage the supply chain complexities for advanced therapies.
Podcast 26 Jul 2024
The first mass-market cell therapy?
Listen to our conversation with CEO Greg Kunst about how Aurion’s treatment could be the first mass-market cell therapy available
Overcoming obstacles as advanced therapies continue to evolve in Europe
Discover strategies to overcome the challenges in advanced therapy development in Europe’s evolving biopharmaceutical landscape.
Best in Biotech 13 Jun 2024
Eight companies tackling cancer with allogeneic cell therapy in 2024
Unlike autologous cell therapy, where the patient’s own cells are used, allogeneic cell therapy companies leverage donor cells, which can come from various sources such as bone marrow or umbilical cord blood. In allogeneic cell therapy, healthy donor cells are harvested, processed, and then infused into the patient. These donor cells can differentiate into various […]
Podcast 31 May 2024
Can cell therapy tackle hearing loss
Hearing loss is a growing global challenge. UK-based Rinri Therapeutics is developing a portfolio of off-the-shelf regenerative cell therapy products to address sensorineural hearing loss.
ADVERTISEMENT
